These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1356748)

  • 1. [The metabolic side effects of beta-receptor blockers].
    Schauer UJ
    Dtsch Med Wochenschr; 1992 Oct; 117(42):1617-8. PubMed ID: 1356748
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blockers, plasma lipids, and coronary heart disease.
    Cruickshank JM
    Circulation; 1990 Sep; 82(3 Suppl):II60-5. PubMed ID: 1975524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers, dyslipidemia, and coronary artery disease. A reassessment.
    Burris JF
    Arch Intern Med; 1993 Sep; 153(18):2085-92. PubMed ID: 8104394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoproteins in plasma and fats in nutrition in the pathogenesis of coronary heart disease. Remarks on the causes and limits of the lipid theory].
    Zöllner N; Keller C
    Internist (Berl); 1984 May; 25(5):261-7. PubMed ID: 6376406
    [No Abstract]   [Full Text] [Related]  

  • 5. [Beta receptor blockers in acute myocardial infarct and in secondary prevention].
    Werdan K
    Internist (Berl); 1991 Jun; 32(6):359-60. PubMed ID: 1679049
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma lipids in men with coronary artery disease. Triglyceride-elevating effect of beta-blockaders].
    Faergeman O; Schläger J; Efsen F; Meinertz H
    Ugeskr Laeger; 1983 Mar; 145(13):978-9. PubMed ID: 6134366
    [No Abstract]   [Full Text] [Related]  

  • 7. [The influence of diuretics and beta receptor blockaders on blood lipids. Adverse effects of practical significance?].
    Naess K
    Tidsskr Nor Laegeforen; 1978 Jan; 98(3):162-3. PubMed ID: 24283
    [No Abstract]   [Full Text] [Related]  

  • 8. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E; Rosenthal T; Goldbourt U; Segal P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoprotein metabolism and beta receptor blockers].
    Schauer UJ; Schauer I
    Z Gesamte Inn Med; 1987 Apr; 42(8):201-5. PubMed ID: 2888241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood lipids and myocardial infarct. Correlation between lipoprotein patterns and coronary heart disease confirmed].
    Schwandt P
    MMW Munch Med Wochenschr; 1984 Feb; 126(8):185-6. PubMed ID: 6425656
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dyslipidemia as a risk factor in atherogenesis].
    Panaitescu G; Fica V; Stănescu L; Serban M; Roşca L; Enache M
    Med Interna (Bucur); 1972 Apr; 24(4):423-40. PubMed ID: 5027788
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperlipoproteinemia in patients hospitalized for ischemic coronary disease and myocardial infarct].
    Cisarik F; Gavalec M; Zánová J; Hrbánová Z
    Vnitr Lek; 1981 Feb; 27(2):137-41. PubMed ID: 7467156
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disorders in the quantitative and qualitative composition of the serum lipoproteins in ischemic heart disease patients].
    Orbetsov G; Orbetsova V; Dakovska L
    Vutr Boles; 1984; 23(5):100-6. PubMed ID: 6523839
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J; Chanu B; Bakir R; Sauvanet JP
    J Pharmacol; 1983; 14 Suppl 2():183-99. PubMed ID: 6138467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current problems in the prevention of sudden cardiac death].
    Anders G
    Z Gesamte Inn Med; 1989 Jan; 44(2):38-41. PubMed ID: 2565069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoproteins--important discriminators for atherosclerotic vascular disease.
    Mordasini R; Riesen WF
    Monogr Atheroscler; 1986; 14():145-9. PubMed ID: 3736553
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in betablocking drugs in cardiovascular therapy.
    Iisalo E; Heikkilä J
    Ann Clin Res; 1988; 20(5):324-33. PubMed ID: 2905877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the sex hormones on the circulating lipids and lipoproteins in coronary sclerosis.
    OLIVER MF; BOYD GS
    Circulation; 1956 Jan; 13(1):82-91. PubMed ID: 13277095
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S; Simons LA; Hickie JB; Chang S
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of beta-adrenoblockaders on the lipid composition of the blood].
    Veĭkin AK; Mukhin EP; Preobrazhenskiĭ DV
    Ter Arkh; 1995; 67(8):30-3. PubMed ID: 7482329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.